SCHEMBL4038176

SCHEMBL4038176

CCC(CC)C(=O)Nc1sc2c(c1C#N)CCC(N(C)Cc1cnc(-c3ccccc3)s1)C2

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 5/20 0.77
ALDH1A1 P00352 6/20 0.46
HTT P42858 2/20 0.46
HSD17B10 Q99714 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPT P10636 8/20 0.44
GAA P10253 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
SAE1 Q9UBE0 1/20 0.44
UBA2 Q9UBT2 1/20 0.44
KCNH2 Q12809 1/20 0.42
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4037178 0.86 GCGR (0.77) GCGRALDH1A1HTTHSD17B10KDM4E
SCHEMBL4039316 0.85 GCGR (0.59) GCGRALDH1A1HTTHSD17B10KDM4E
SCHEMBL4040353 0.81 GCGR (0.82) GCGRALDH1A1MAPTL3MBTL1NPC1
SCHEMBL4035540 0.79 GCGR (0.77) GCGRALDH1A1HSD17B10KDM4EMAPT
SCHEMBL4038178 0.77 GCGR (0.46) GCGRALDH1A1HTTHSD17B10KDM4E
SCHEMBL4037335 0.77 GCGR (0.72) GCGRALDH1A1HTTHSD17B10KDM4E
SCHEMBL2648406 0.76 GCGR (0.70) GCGRALDH1A1HTTHSD17B10KDM4E
SCHEMBL4037054 0.76 GCGR (0.72) GCGRALDH1A1HTTMAPTL3MBTL1
SCHEMBL4046144 0.75 GCGR (0.59) GCGRALDH1A1HTTHSD17B10KDM4E
SCHEMBL6316704 0.74 GCGR (0.71) GCGRALDH1A1HTTHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 963 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549655-B1 SUBSTITUTED BICYCLIC THIOPHENE DERIVATIVES, COMPOSTIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO INC (US) 2009-01-21 EP claimed
EP-1549655-A4 SUBSTITUTED BICYCLIC THIOPHENE DERIVATIVES, COMPOSTIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO INC (US) 2006-05-31 EP claimed
US-20050239865-A1 Substituted bicyclic thiophene derivatives, compositions containing such compounds and methods of use MERCK SHARP & DOHME CORP. 2005-10-27 US claimed
EP-1549655-A2 SUBSTITUTED BICYCLIC THIOPHENE DERIVATIVES, COMPOSTIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Merck & Co., Inc. (US) 2005-07-06 EP claimed
WO-2004024065-A2 SUBSTITUTED BICYCLIC THIOPHENE DERIVATIVES, COMPOSTIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO., INC. (US) 2004-03-25 WO claimed
US-12048207-B2 Display device and method for manufacturing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-07-23 US disclosed
US-20240237435-A1 Semiconductor Device, Display Apparatus, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-07-11 US disclosed
US-12034080-B2 Semiconductor device, method for manufacturing the same, or display device including the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-07-09 US disclosed
US-20240213356-A1 METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-06-27 US disclosed
US-12002876-B2 Semiconductor device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-06-04 US disclosed
US-20240173014-A1 ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-05-30 US disclosed
US-20240179987-A1 Display Apparatus, Electronic Device, and Method of Manufacturing Semiconductor Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-05-30 US disclosed
US-7476420-B2 Process for producing metal oxide films at low temperatures ASM INTERNATIONAL N.V. (NL) 2009-01-13 US disclosed
US-20080318423-A9 PROCESS FOR PRODUCING METAL OXIDE FILMS AT LOW TEMPERATURES SKARP JARMO 2008-12-25 US disclosed
US-7273876-B2 Substituted bicylic thiophene derivatives, compositions containing such compounds and methods of use MERCK & CO., INC. (US) 2007-09-25 US disclosed
EP-1549655-A4 SUBSTITUTED BICYCLIC THIOPHENE DERIVATIVES, COMPOSTIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO INC (US) 2006-05-31 EP disclosed
US-20050239865-A1 Substituted bicyclic thiophene derivatives, compositions containing such compounds and methods of use MERCK SHARP & DOHME CORP. 2005-10-27 US disclosed
EP-1549655-A2 SUBSTITUTED BICYCLIC THIOPHENE DERIVATIVES, COMPOSTIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Merck & Co., Inc. (US) 2005-07-06 EP disclosed
US-20050112874-A1 Process for producing metal oxide films at low temperatures ASM INTERNATIONAL N.V. (NL) 2005-05-26 US disclosed
WO-2004024065-A2 SUBSTITUTED BICYCLIC THIOPHENE DERIVATIVES, COMPOSTIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO., INC. (US) 2004-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239865-A1 Substituted bicyclic thiophene derivatives, compositions containing such compounds and methods of use GLP1R, GCGR, GPR119 GCGR 2/4885ALDH1A1 4206/4885HTT 2047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.